BlossomHill Therapeutics (BLSM) stock, explained like you're 5

Is BlossomHill Therapeutics a small, medium or large cap company?

No. BlossomHill Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 556 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How BlossomHill Therapeutics makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves BLSM stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• BlossomHill Therapeutics (NASDAQ:BLSM) Stock Price Down 7% What's Next? (MarketBeat)
• Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO (Latham & Watkins LLP)
• BlossomHill Therapeutics, Inc. Rings the Nasdaq Stock Market Opening Bell (Nasdaq)
• An experimental cancer drug shrank tumors in models of pancreatic, lung and colorectal cancer. (Stock Titan)
• Insider Purchase: Chief Financial Officer of $BLSM Buys 700 Shares (Quiver Quantitative)

Key terms to know before you follow BLSM

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility